Plus Therapeutics is a clinical-stage pharmaceutical company based in the United States, trading under the ticker PSTV on Nasdaq. The company leverages a hybrid virtual drug development model, which is designed to be capital efficient and to enhance operational efficiencies. This approach helps in reducing costs and accelerating the development of its products. Plus Therapeutics is supported by a strong network that includes talented executives as well as a nationwide pool of scientists, engineers, and physicians, indicating a solid foundation for research, development, and innovation in its pharmaceutical endeavors.